Is MET a good stock to buy?
MetLife, Inc. · end-of-day data as of Nov 13, 2026
- PT$108.00 +5.2%
- ConsensusBuy · 18
- FCF yield+23.3%
- News
- Trendbullish
- MAs4 of 4
- MACD0.11
- Sector▲ -1.8%
- Earnings in82d
- P/E13.4x
- RSI58
- Support-4.8%
- Off 52w high-3.8%
- Volume0.8x
- Bollingerupper half
- P/E vs own-9.2%
- P/E vs sector-7.7%
- 52w range$67–$107
- ATR+2.4%
- Off ATH-3.8%
- Insiders-$19.3M
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is MetLife a good stock to buy?
MetLife is weak on economics; demand, execution and fragility in between. The price is low: 13.4 times its earnings, below its 3-year median of 15.9 (Nov 13, 2026). pretickt does not say whether to buy or sell.
MET earnings vs estimates
5 of 8quarters above the analysts' estimateMetLife beat the analysts' profit estimate in 5 of its last 8 quarters, the latest on Nov 4, 2026.
MET insider selling
-$19.3Msold, net, by its executives in 12 monthsMetLife's executives and directors sold a net $19.3M of shares in the 12 months to Nov 13, 2026; none bought.
MET number of employees
+2%more people in a yearMetLife had 46,000 employees at the end of fiscal 2025, 2% more than a year before.
MET CEO pay
$22.36Mfor fiscal 2025, 66% of it in stock and optionsMetLife paid its CEO $22.36M for fiscal 2025, 66% of it in stock and options.
MET biggest customers
under 10%of sales from any one customerNo customer made 10% of MetLife's sales in fiscal 2025.
MET in past recessions
pretickt analysis-19%its sales in the worst oneMetLife's sales fell in each of the last 2 US recessions, by as much as 19% in fiscal 2009.
MET price vs profit P/E ratio
13.4×a year's earningsMetLife's P/E ratio is 13.4 (Nov 13, 2026), below its 3-year median of 15.9.
MET price vs assets price to book
2.9×times what its assets are worth on paperMetLife trades at 2.9 times its book value (Nov 13, 2026); its peers' median is 2.0.
MET price vs peers
pretickt analysis13.4×a year's earnings, against its peersInvestors pay 13.4 times MetLife's earnings (Nov 13, 2026), more than for Prudential Financial (11.1), Globe Life (10.7) and Allstate (6.1), less than for Aflac (18.7).
MET analysts' target price target
+5%to their average targetAnalysts' average price target for MetLife is $108, 5% above the Nov 13, 2026 close of $102.65.
MET analyst ratings, 90 days
pretickt analysisPiper Sandlerupgrade
In the 90 days to Nov 13, 2026, Piper Sandler upgraded MetLife.
What is MetLife's P/E ratio?
MetLife's P/E ratio is 13.4 (Nov 13, 2026), below its 3-year median of 15.9. Investors pay 13.4 times MetLife's earnings (Nov 13, 2026), more than for Prudential Financial (11.1), Globe Life (10.7) and Allstate (6.1), less than for Aflac (18.7).
Are insiders selling MetLife stock?
MetLife's executives and directors sold a net $19.3M of shares in the 12 months to Nov 13, 2026; none bought.
Who owns MetLife stock?
1,521 institutions hold 75% of MetLife's shares (Jun 30, 2026); BlackRock added shares that quarter, Vanguard and Dodge & Cox sold some.
How many employees does MetLife have?
MetLife had 46,000 employees at the end of fiscal 2025, 2% more than a year before.
Who are MetLife's biggest customers?
No customer made 10% of MetLife's sales in fiscal 2025.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.